P030002 CrystaLens™ Model AT-45 Multipiece Silicone Posterior Chamber Accommodating IOL.

Slides:



Advertisements
Similar presentations
EXPERIENCE WITH THE LENSTEC KH3500 TETRAFLEX LENS.
Advertisements

Dr H. Razmjoo Isfahan University of Medical Sciences Multifocal IOLs
Stratus OCT Non-invasive optical diagnostic techniques that would provide images of high resolution for the measurement and diagnosis of ocular tissues,
PMA P Phakic IOL for the correction of Myopia.
V. S. Liarakos, K. van Dijk, L. Ham, L. Baydoun and G.R.J. Melles Anterior Chamber vs Posterior Chamber IOL in DMEK for Pseudophakic Bullous Keratopathy.
Visual outcome & subjective visual symptoms of the Tecnis ZM900 multifocal intraocular lens in Asian eyes Dr Colin S.H. Tan MBBS, MMed (Ophth), FRCSEd.
Multifocal Intraocular Lenses & Contrast Sensitivity
NEW TRULIGN™ TORIC IOL Surgeon Training
Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster.
A Prospective, Randomized, Comparative Evaluation of Patients with Contralateral Implantation of Two Aspheric Acrylic Intraocular Lenses R. Cionni, MD.
CLINICAL OUTCOMES WITH A NEW DIFFRACTIVE MULTIFOCAL INTRAOCULAR LENS (IOL) Pilar Casas de Llera Ana Belen Plaza Alfredo Vega-Estrada Jorge L Alio Vissum.
Eltutar, Kadir; Akcetin, Tulay A.; Ozcelik, N. Demet Istanbul Education and Research Hospital Department of Ophthalmology The authors state that they have.
Ruth Lapid-Gortzak MD PhD 1,2, Jan Willem van der Linden BOpt 2, and Ivanka J. van der Meulen MD 1,2 1 Department of Ophthalmology, Academic Medical Center,
Disclosure of finanacial interest * Author has no financial interest in this paper. ** Author's research is partially funded by Imperial Medical Technologies.
Progressive Multifocal Intraocular Lens G. Rubiolini M.D. Italy Disclosure of finanacial interest Author's research is partially funded.
1 Clinical Performance of the Crystalens® AO Guy M. Kezirian, MD, FACS.
Retrospective Comparison of 3177 Eyes Implanted with Presbyopic IOLs Carlos Buznego MD Elizabeth A. Davis MD, FACS Guy M. Kezirian MD, FACS William B.
Hyperopia Walter Huang, OD Yuanpei University Department of Optometry.
PMA P010018/SUPPLEMENT 5 FDA PRESENTATION. Indication for Use Temporary induction of myopia (-1D to -2D) to improve near vision in the non- dominant eye.
Panel Questions 1.Please discuss the following regarding endothelial cell density: a.The primary safety endpoint for this study was mean ECD ≤ 17%. The.
Bret Fisher, MD The Eye Center of North Florida Panama City, FL
Accommodative Arching Eyeonics Briefing 2 February 2005 Kevin L. Waltz, OD, MD Eye Surgeons of Indiana Indianapolis, IN.
Blended vision after bilateral monofocal cataract surgery: an evaluation of spectacle independence and vision related quality of life Allison Landes, MD.
USAMA MOURIS BEBAWY, MB MBCh CLINICAL FELLOW, MCMASTER UNIV No Financial Disclosure GEORGE H.H. BEIKO, B.M.,B.Ch.,FRCSC ST. CATHARINES, CANADA ASSIST PROF,
Neeti Parikh, MD Fuxiang Zhang, MD Department of Ophthalmology Henry Ford Hospital A Comparison Of Patient Satisfaction With Modified Monovision Versus.
A Fellow Eye Comparison of Aberrations, Modulation Transfer Function and Contrast Sensitivity After AcrySof IQ and AcrySof Natural IOL Implantation. Mayank.
Clinical and simulation outcomes of a multifocal intraocular lens with rotational asymmetry and two different levels of near addition Jorge Alió, MD,PhD.
Astigmatism management with toric intraocular lenses in cataract patients Adriano Guarnieri 1-2, Luis W. Lu 3-4, Alfonso Arias- Puente INCIVI, Madrid,
Use of Multifocal IOLs in Patients with Age-Related Macular Degeneration Helga P. Sandoval, MD, MSCR 1 Reid B. Murphy, MD, 1 Luis E. Fernández de Castro,
P91: Clinical Performance of Phakic Angle-Supported Investigational IOL in Prospective Global Trials, ASCRS 2010, Boston P91: Clinical performance of phakic.
Preoperative and Postoperative Glarometer Measurements in Patients Having Cataract Extraction with Placement of Posterior Chamber and Accommodating IOLs.
Evaluation Of The Tetraflex and Crystalens Accommodative IOLs Using the iTrace Aberrometer Donald R. Sanders, M.D., PhD. David C. Brown M.D. Deepak Chitkara,
P The Implantable Miniature Telescope (IMT™) Presented by Bernard P. Lepri, OD, MS, MEd FDA/CDRH/ODE/DOED July 14, 2006.
Kaori Morii, M.D. Shinji Miura, M.D, Ph.D. Dept. of Ophthalmology, Asagiri Hospital, Hyogo, JPN We have no financial interest. This retrospective study.
Results of Collagen Crosslinking followed by posterior chamber toric implantable collamer lens implantation in patients with Keratoconus & High Myopia.
A case of hypermature cataract formation following implantation of a posterior chamber phakic intraocular lens with a central hole The Catholic University.
Effect of Ocular Deviation on Pupil size with Implanted Multifocal Intraocular Lens Yoshihiko Iida, MDKimiya Shimizu, MD Misae Ito, CO Kitasato University.
Partial Coherence Interferometry Failure Rate in a Teaching Hospital Leslie A. Wei 1,2, BA, Nickolaus P. Katsoulakis 2, MD, Theodoros Filippopoulos 3,
Refractec ViewPoint™ CK System for the Treatment of Spherical Hyperopia Sheryl Berman, MD Medical Officer FDA/CDRH/ODE/DOED.
Adriana S. Forseto1, MD Walton Nosé1,2, MD
Binocular Defocus Curve of Apodized Diffractive Multifocal IOL in Asian-Indian Eyes Dr.A. Shetty; Dr. M. K. Kummelil; Dr. S.Nagappa Cataract and Refractive.
DGII 2008 Comparison of Aspheric ReSTOR and Tecnis multifocal IOL Dongho Lee MD, PhD Yonsei eye center, Seoul, South Korea No Financial Interest.
AcrySof ® ReSTOR ® Aspheric IOL. Aspheric IOL AcrySof ® ReSTOR ® 2 AcrySof ® ReSTOR ® Aspheric IOL SN6AD3 Add Power: +4 D Spectacle Plane: 3.2 D Range:
Controversies about binocular function and patient satisfaction after induced conventional monovision in case of bilateral intraocular lens implantation.
LogMAR-Analysis of multifocal intraocular lenses: Clinical performance A. Mannsfeld, I.-J. Limberger, A. Ehmer, M.P. Holzer, G. U.Auffarth International.
AcrySof ® ReSTOR ® Apodized Diffractive IOL. What is the AcrySof ® ReSTOR ® IOL? The AcrySof ® ReSTOR ® IOL incorporates an apodized diffractive optic.
I have no financial interest in any devices or techniques discussed in this presentation.
Comparison of 2 Models of Aspheric Diffractive Multifocal IOL
O.I.I. EC-3 Hydrophobic Acrylic Intraocular Lens: The European Experience Thierry Amzallag, M.D. Institut Ophtalmique Somain, France.
Investigation of Multifocal Toric IOLs to Compensate for Corneal Astigmatism and to Provide Near, Intermediate, and Distance Vision José L. Rincón, MD.
Preliminary Results after Cataract Surgery with the Aspheric Acrysof ReSTOR IOL to Correct Presbyopia Meeting of the ASCRS Chicago 8-10 February 2007 R.M.M.A.
Vision Changes with Aging Mark Swanson, OD, MSPH Associate Professor.
Inadvertent Insertion of an Opposite- Side Tecnis ZM900 Multifocal IOL Wilson Takashi Hida, M.D. Celso Takashi Nakano; Jonathan Lake;
9-Month Results after Implantation of a new accommodative IOL that works with one focus Mark Tomalla M.D.* Clinic for Refractive and Ophthalmic Surgery,
Examples of Accommodation Evaluation with the Tracey 3-D Difference Maps Tracey Technologies, Corp.
Lifestyle and Refractive Factors Associated with Progressive Addition Lens Preference The Center for Ophthalmic Optics Research, The Ohio State University.
"Mix and Match" approach implantation
Corneal CXL in Pediatric Patients with Progressive Keratoconus Stephanie Wise, Christian Diaz, Karolien Termote, Paul J. Dubord, Martin McCarthy, Sonia.
Outcomes Update for an Aspheric Accommodating IOL John A. Hovanesian, M.D. Clinical Instructor, UCLA Jules Stein Eye Institute Harvard Eye Associates,
Studený P., Dědková B., Farkaš A., Vokrojová M., Siveková D., Břešťák M. Oční klinika FNKV a 3 LF UK Praha Oční oddělení, Karlovarská krajská nemocnice.
Am J Ophthalmol 2009;147:357–363 Ap.신선영/R4 권진우
Postoperative Refraction and Patient Satisfaction after Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses Robert Cionni, MD Financial.
B. Kozomara, E. Potkonjak, R. Lazic, N. Gabric
Clinical results of the aphakia correction using iris-fixated anterior chamber intraocular lens (Artisan) Authors have no financial interest Luis Izquierdo.
Long Term Clinical Outcomes of Refractive Lens Exchange in Moderate     to High Hyperopia Frank Goes, BELGIUM Ascrs 2008.
Thomas Kohnen, MD Department of Ophthalmology
Comparison of vision with an accommodating IOL versus a multifocal IOL
David T. Vroman, MD Assistant Professor of Ophthalmology
Kellan Tetraflex KH3500 Accommodative IOLs vs. Acri
Z deformity of an acommodative IOL
Presentation transcript:

P CrystaLens™ Model AT-45 Multipiece Silicone Posterior Chamber Accommodating IOL

Bernard P. Lepri, OD, MS, MEd Clinical Reviewer FDA/DOED

Information for Question #1

Accommodative Substudies A small subset of five subjects implanted bilaterally with the CrystaLens™ at a single clinical site underwent additional testing in an effort to document the mechanism of action of the CrystaLens™, i.e., accommodation achieved by the forward and backward movement of the lens optic along the axis of the eye. A small subset of five subjects implanted bilaterally with the CrystaLens™ at a single clinical site underwent additional testing in an effort to document the mechanism of action of the CrystaLens™, i.e., accommodation achieved by the forward and backward movement of the lens optic along the axis of the eye.

Testing included: dynamic retinoscopydynamic retinoscopy defocus defocus near point evaluation near point evaluation near vision (DxRx cycloplegia) near vision (DxRx cycloplegia) power mapping (Tracey Wavefront) power mapping (Tracey Wavefront) anterior chamber depth ( A-scan ) (cyclopentolate) / 6% pilocarpine.anterior chamber depth ( A-scan ) (cyclopentolate) / 6% pilocarpine.

Mean(±SD) ∆ ACD In mm 0.56mm(0.39) ∆ ACD In D* 1.01 D (0.70) TraceyAbberrometerAccommodation 0.72 D (0.83) Dynamic Retinoscopy 3.14(0.81) Defocus2.43(0.46) Lagenbacher: 1.0mm = 1.8D Accommodative Substudy Summary (n = 10)

Correlation of Accommodative Studies Abb Vs ACD ∆ (D) Abb. Vs retinoscopy Retinoscopy Vs defocus Abb. Vs defocus- ACD ∆(D) Vs defocus R corr

Question #1 This is the first IOL that proposes accommodation as its mechanism of action. This is the first IOL that proposes accommodation as its mechanism of action. a). Do the effectiveness data support a claim of accommodation? a). Do the effectiveness data support a claim of accommodation? b). What performance issues should be considered both generally and for product labeling?

Information for Question #2 The stability of the CrystaLens hinge was demonstrated by: a). in-vitro dynamic fatigue testing up to 1-year b). an analysis of change Dx MRSE between consecutive examinations c). intermediate visual acuity between consecutive examinations

Stability of MRSE Primary Eyes

∆ MRSE Form 3 to 4 %* (n) %* (n) Form 4 to 5 %* (n) %* (n)   0.50 D95% CI 84.1% (206) 84.1% (206) (79.5%, 88.7%) 85.6% (202) 85.6% (202) (81.1%, 90.1%)   1.00 D 95% CI   1.00 D 95% CI 96.3% (236) 96.3% (236) (94.0%, 98.7%) 96.2% (227) 96.2% (227) (93.7%, 98.6%) Mean SD 95% CI mean, Median  Range   0.52 (-0.09, 0.04) (-0.09, 0.04) to   0.45 (0.08, 0.19) to 2.75

∆ UCVA Form 3 to 4 % (n) % (n) Form 4 to 5 % (n) % (n) Decrease  2 lines ± 1 line Increase  2 lines 6.1% ( 14) 6.1% ( 14) 80.8% (185) 13.1% ( 30) 4.4% ( 10) 4.4% ( 10) 81.1% (185) 14.5% ( 33) 81.1% (185) 14.5% ( 33) Mean  SD 95% CI for mean MedianRange 0.27  1.33 (0.10, 0.44) 0.27  1.33 (0.10, 0.44)0 -3 to 5 -3 to  1.16 (0.14, 0.44) 0.29  1.16 (0.14, 0.44)0 -4 to 3 Stability of Uncorrected Near Visual Acuity (UNVA) US Eyes One-Year Consistent Cohort One-Year Consistent Cohort

Visual Acuity Primary Eyes N = 241N (Missing) = 5 (Missing) = 5 Fellow Eyes N = 127N N = 127N (Missing) = 0 (Missing) = 0 n%n% 20/20 or better 20/25 or better 20/32 or better 20/40 or better /41 to 20/100 Worse than 20/ Intermediate Visual Acuity Through Distance Correction (DCIVA) US Eyes

Question #2 Do you believe that the sponsor has demonstrated the stability of the hinge, and therefore the stability of the accommodative refractive effect? Do you believe that the sponsor has demonstrated the stability of the hinge, and therefore the stability of the accommodative refractive effect?

Question #3 Does the panel recommend any other Does the panel recommend any other modifications to the proposed : modifications to the proposed : a). Physician labeling? b). Patient labeling?

Question # 4 Do the data in PMA P support the proposed indication statement? Do the data in PMA P support the proposed indication statement?

Primary implantation for the visual correction of aphakia in adult patients with cataracts. Primary implantation for the visual correction of aphakia in adult patients with cataracts. Provide improved near, intermediate, and distance vision without spectacles. Provide improved near, intermediate, and distance vision without spectacles. Indications for use: